GMAB:CPH
Genmab
2 487,00 DKK
arrow_upward
+1,72%(+42,00) 1 d.
12. 10., 17:00:00 GMT+2 · DKK
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre GMAB…
Otvoriť
2 468,00 DKK
Vysoká
2 504,00 DKK
Nízka
2 459,00 DKK
Trh. kap.
152,72 mld.
Priem. obj.
128,35 tis.
Objem
105,44 tis.
Max. za 52 týž.
2 603,00 DKK
Min. za 52 týž.
1 512,00 DKK
Akcie v obehu
62,41 mil.
Počet zamestnancov
3 tis.
Otvoriť
2 468,00 DKK
Vysoká
2 504,00 DKK
Nízka
2 459,00 DKK
Trh. kap.
152,72 mld.
Priem. obj.
128,35 tis.
Objem
105,44 tis.
Max. za 52 týž.
2 603,00 DKK
Min. za 52 týž.
1 512,00 DKK
Akcie v obehu
62,41 mil.
Počet zamestnancov
3 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Stocktwits
·
pred 31 minútami
Big Banks Kick Off Q3 Earnings With S&P 500 Near Records — Strategists Flag What Could Move Markets
www.marketscreener.com
·
pred 1 hodinou
Nextdoor Holdings, Inc. Primary Exchange Listing will Change to Nasdaq Capital Market from New York Stock Exchange
Cryptonews.net
·
pred 23 minútami
Evernorth Hits Nasdaq With 473 Million XRP as XRPN Trading Begins
Profil
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Informácie o subjekte Genmab
Generálny riaditeľJan G. J. van de Winkel
Zamestnanci3,12 tis.
Dátum založenia11. 6. 1998
Hlavné sídlo-
Odvetvie-
Webgenmab.com